What is ClearFlow?
ClearFlow is a medical technology firm dedicated to advancing patient care in cardiac surgery. The company's core offerings, including the PleuraFlow Active Clearance Technology and ClearFix Rigid Sternal Fixation, are engineered to mitigate complications such as Retained Blood Syndrome and accelerate patient recovery. ClearFlow's strategic focus is on integrating its innovative solutions within healthcare systems, aiming to optimize resource allocation and improve surgical recovery pathways. Their commitment extends to professional education and support for medical practitioners in the cardiac care field.
How much funding has ClearFlow raised?
ClearFlow has raised a total of $21.8M across 8 funding rounds:
Private Equity
$1.2M
Private Equity
$4.9M
Private Equity
$4.2M
Debt
$2.8M
Private Equity
$5.5M
Debt
$350K
Debt
$2.1M
Private Equity (2010): $1.2M, investors not publicly disclosed
Private Equity (2011): $4.9M, investors not publicly disclosed
Private Equity (2013): $4.2M, investors not publicly disclosed
Debt (2014): $2.8M, investors not publicly disclosed
Private Equity (2015): $5.5M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2025): $2.1M, investors not publicly disclosed
What's next for ClearFlow?
The recent major strategic investment signals a pivotal growth phase for ClearFlow. This capital infusion is expected to accelerate the development and market penetration of its advanced medical technologies. The company is poised to expand its reach within cardiac surgery departments, further solidifying its position as a key innovator. Future endeavors will likely involve scaling operations, enhancing product lines, and potentially exploring new therapeutic areas within cardiovascular care, leveraging this substantial financial backing to drive innovation and market leadership.
See full ClearFlow company page
